Discover 372 paid clinical trials in Virginia Beach, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 372
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Norfolk VA, Chapel Hill NC, Philadelphia PA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase2, Recruiting
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Norfolk VA, Richmond VA, Philadelphia PA, Morristown NJ,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04637763
Phase1, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Norfolk VA, Washington D.C. DC, Fairfax VA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: Norfolk VA, Washington D.C. DC, Fairfax VA,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase2, Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Location: Norfolk VA, Fairfax VA, Washington D.C. DC, Raleigh NC,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase1, Phase2, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Norfolk VA, Washington D.C. DC, Raleigh NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase3, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Norfolk VA, Newark DE, Christiansburg VA, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase3, Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Norfolk VA, Fairfax VA, Atlanta GA, Nashville TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07266441
Phase2, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Norfolk VA, Fairfax VA, Columbia MD, Durham NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for
Chronic Lymphocytic Leukemia (CLL),
Location: Norfolk VA, Fairfax VA, Silver Spring MD, Durham NC,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07221500
Phase2, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Norfolk VA, Silver Spring MD, Allentown PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase2, Phase3, Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Norfolk VA, Durham NC, Hackensack NJ, Buffalo NY,